NCT01759628View on ClinicalTrials.gov

Helicobacter Pylori Eradication in Subjects With Non-alcoholic Fatty Liver Disease

PHASE2CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

April 30, 2012

Primary Completion Date

June 30, 2013

Study Completion Date

June 30, 2013

Conditions
Non-alcoholic Fatty Liver Disease
Interventions
DRUG

H.pylori eradication

The regimen consists of Omeprazole (20 mg/BD)+ Amoxicillin (1 g/day)+ Bismuth subcitrate (240 mg/BD)+ Azithromycin (500 mg/BD)for two weeks

Trial Locations (1)

Unknown

Gastroenterology clinic, Sina Hospital (Tehran) / Beheshti Hospital (Kashan), Tehran / Kashan

All Listed Sponsors
collaborator

Kashan University of Medical Sciences

OTHER

lead

Tehran University of Medical Sciences

OTHER

NCT01759628 - Helicobacter Pylori Eradication in Subjects With Non-alcoholic Fatty Liver Disease | Biotech Hunter | Biotech Hunter